Back to search

Article

Atogepant modulates brain connectivity in episodic migraine: a longitudinal cohort fMRI study

2025-12-30

Abstract excerpt

<title>Abstract</title> <p>Background Episodic Migraine (EM) is a highly prevalent and disabling neurological disorder. Recent therapeutic advances have targeted the calcitonin gene-related peptide (CGRP), a neuropeptide implicated in the pathophysiology of migraine. Promising outcomes have been obtained with monoclonal antibodies and, more recently, with a new class of drugs consisting of small-molecule CGRP re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
42bd21b2-4cdb-5691-8bd5-459436f92247
DOI
10.21203/rs.3.rs-8406852/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Atogepant modulates brain connectivity in episodic migraine: a longitudinal cohort fMRI studyDOI 10.21203/rs.3.rs-8406852/v1
Atogepant: Mechanism of action, clinical and translational scienceSemantic proximity
Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization.Semantic proximity
Treating episodic migraine with precision: the evolving landscape of targeted therapies driven by insights in disease biologySemantic proximity
Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-AnalysisSemantic proximity
Cluster Headache and Migraine Shared and Unique Insights: Neurophysiological Implications, Neuroimaging, and Biomarkers: A Comprehensive ReviewSemantic proximity
Migraine Treatment: Towards New Pharmacological TargetsSemantic proximity
Effectiveness and Tolerability of Repetitive Transcranial Magnetic Stimulation for Preventive Treatment of Episodic Migraine: A Single Centre, Randomised, Double-Blind, Sham-Controlled Phase 2 Trial (Magnet-EM).Semantic proximity
Temporal stability and neural complexity in resting-state MEG predict migraine phenotypes.Semantic proximity
Three-month treatment with monoclonal antibodies targeting the CGRP pathway is associated with multi-domain improvement of sensory processing and cortical network efficiency: results from a prospective case-control studySemantic proximity
Neuroimaging-based subtyping of migraine identifies clinically distinct phenotypes.Semantic proximity
Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceSemantic proximity
Comparative Efficacy and Safety of Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Oral Gepants for Episodic Migraine Prevention: A Bayesian Network Meta-Analysis of Randomized Controlled TrialsSemantic proximity
Select a neighboring publication to make it the new centre.